Case Study Category: Andrea De Censi

Early-stage breast cancer: more effective and less toxic post-operative therapy with low-dose Tamoxifen

Early-stage breast cancer: more effective and less toxic post-operative therapy with low-dose Tamoxifen

The international study coordinated by the Istituto Europeo di Oncologia (IEO) and the Champalimaud Foundation, in Lisbon, is changing the post-surgical standard of care for breast tumours in women with ductal carcinoma in situ and high-risk lesions. The research findings, recently…

Read More
Andrea-De-Censi_external_comm_02-square

Welcome to Andrea De Censi, New Director of the Breast Unit

With more than three decades of pioneering work in breast cancer prevention, Dr Andrea De Censi, has joined the Champalimaud Foundation as the new Director of the Breast Unit. An internationally recognised medical oncologist and a leader in chemoprevention, Dr De…

Read More